In summary, we uncovered a novel CDK1-mediated phosphorylation of KDM6A at Ser829 that connects epigenetic silencing of PER2 and glycolytic activity in HNSCC. The gene discussed is PER2; the disease is head and neck squamous cell carcinoma.